Skip to search formSkip to main contentSkip to account menu

adibendan

Known as: 7,7-dimethyl-2-(4-pyridyl)-6,7-dihydro-3H,5H pyrrolo (2,3-f)benz-imidazol-6-one, Pyrrolo(2,3-f)benzimidazol-6(1H)-one, 5,7-dihydro-7,7-dimethyl-2-(4-pyridinyl)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
SummaryThe present study was performed to compare the effects of the new positive inotropic phosphodiesterase III inhibitors… 
2004
2004
Summary1.The effects of adibendan (BM 14.478; 7,7-dimethyl-2-(4-pyridyl)-6,7-dihydro-3H,5H-pyrrolo[2,3-fl benzimidazole-6-one) on… 
1992
1992
Positive inotropic effects of phosphodiesterase inhibitors like 3-isobutyl-1-methylxanthine (IBMX), pimobendan, adibendan… 
1992
1992
Four cyclic AMP (cAMP)-phosphodiesterases (PDE) belonging to families I, II, III and IV were identified in homogenates from human… 
1992
1992
Summary: The cardiac in vitro effects of R 80122, a novel phosphodiesterase (PDE) inhibitor, were investigated and compared with… 
1990
1990
1 This study was performed to investigate whether cardiac positive inotropic as well as peripheral vasodilator properties of… 
1989
1989
We previously reported the structure-activity relationships (SAR) of adibendan (1), a potent and long-acting cardiotonic. This… 
1989
1989
Myocardial contractile force may be altered not only by changing intracellular free Ca2+ but also by increasing or decreasing the… 
1989
1989
Several cardiotonic agents (MCI-154, sulmazole, pimobendan and adibendan) were examined for their ability to influence Ca2… 
1988
1988
Summary: BM 14.478 (7,7-dimethyl-2-(4-pyridyl)-6,7-dihydro-3H,5H pyrrolo[2,3-f]benz-imidazol-6-one) was investigated in several…